Compounded Medication

TB-500

TB-500 is a synthetic peptide corresponding to an active region (the LKKTETQ sequence) of Thymosin Beta-4, a protein that occurs naturally in many tissues of the body. The fragment has been studied in preclinical literature in connection with cell-migration and wound-response signaling.
MediVera compounding pharmacist in grey scrubs reviewing a prescription on a clipboard in front of pharmacy shelves stocked with medication bottles

About TB-500

TB-500 is a synthetic peptide corresponding to an active region (the LKKTETQ sequence) of Thymosin Beta-4, a protein that occurs naturally in many tissues of the body. As a peptide class, the Thymosin Beta-4 fragment has been studied in preclinical literature in connection with cell-migration and wound-response signaling. Any activity described is attributed to the fragment as studied in laboratory and animal models, not to any specific compounded preparation.

This peptide class is currently under evolving regulatory review. Information listed here is for educational purposes only and is not intended as medical advice or a promotion of any specific product. Compounded medications are not evaluated by the FDA for safety or efficacy. This information does not imply availability of TB-500 through MediVera Compounding Pharmacy™.

Our Current Peptide Offerings

*Compounded medications are prepared based on a healthcare provider’s prescription to meet individual patient needs. These medications are not FDA-approved, and no claims are made regarding their safety, efficacy, or quality. While we offer compounded medications tailored to individual needs, we also have commercially available drugs for patients when appropriate. All doses listed are common doses; customized medication strengths are also available as prescribed by a licensed provider.

Related Products

Learn More

How Patients Can Engage With Us